Merrimack to sell off its cancer drugs, slashes workforce by 80% By: MarketWatch January 08, 2017 at 21:08 PM EST Merrimack Pharmaceuticals Inc. agreed to sell oncology assets including the pancreatic cancer drug Onivyde to French drug maker Ipsen SA. Read More >>